聚乙醇酸膜覆盖预防胃ESD术后迟发出血的前瞻性多中心研究
这项日本13家机构的前瞻性单臂确证性研究纳入125例接受抗凝药或双联抗血小板治疗的胃肿瘤ESD患者,术后在溃疡面应用聚乙醇酸膜联合纤维蛋白胶覆盖。28天内迟发出血发生率为10.4%(95%CI 5.7-17.1%),未达到预设15%的疗效阈值(p=0.09),DAPT组出血率28.6%高于抗凝药组9.3%。
要点
- 抗凝/DAPT患者胃ESD后PGA膜覆盖的迟发出血率为10.4%,未达预设15%阈值
- DAPT组迟发出血率28.6%,明显高于抗凝药组的9.3%
- 仍需对照研究确认PGA膜覆盖在该高危人群中的临床获益
核心结论
- 预设疗效阈值未达到,抗凝药或DAPT患者胃ESD后PGA膜覆盖的28天迟发出血率为10.4%。
研究设计与样本
- 日本13家机构开展的多中心、前瞻性、单臂确证性研究,纳入接受抗凝药或DAPT的胃肿瘤ESD患者125例。
主要发现
- 28天内迟发出血13例(10.4%,95%CI 5.7-17.1%),未达到预设15%阈值(p=0.09)。
- 晚期迟发出血发生率为7.2%。
- DAPT组出血率为28.6%,抗凝药组为9.3%。
- 需输血者占5.6%,血栓栓塞事件发生率为0.8%。
关键数值与推荐
- 主要终点为28天内迟发出血,预设疗效阈值为15%。
- 迟发出血10.4%(95%CI 5.7-17.1%),未达到15%阈值(p=0.09)。
临床怎么用
- 该研究未证实PGA膜覆盖在抗凝/DAPT患者胃ESD后能达到预设的迟发出血控制目标。
- DAPT患者术后迟发出血风险较高,需加强监测与个体化预防策略。
局限性
- 单臂设计,缺乏对照组,无法确定PGA膜覆盖相对于无覆盖的临床获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Delayed bleeding after gastric endoscopic submucosal dissection (ESD) remains a significant clinical complication, particularly in patients receiving anticoagulants/ dual antiplatelet therapy (DAPT). However, effective preventive measures are not established and the efficacy of endoscopic shielding using polyglycolic acid (PGA) sheets with fibrin glue in this high-risk population remains unclear. This study prospectively evaluated the efficacy of PGA sheets and fibrin glue shielding in preventing delayed bleeding after gastric ESD in patients receiving anticoagulants/ DAPT. METHODS: This multicenter, prospective, single-arm confirmatory study was conducted at 13 Japanese institutions. Patients with gastric neoplasms who underwent ESD while receiving anticoagulants/DAPT were enrolled. Following standard ESD and prophylactic coagulation, PGA sheets and fibrin glue were applied to the ulcer beds. The primary endpoint was delayed bleeding within 28 days. Secondary endpoints included late delayed bleeding, transfusion, emergency endoscopy, and thromboembolic events. RESULTS: We included 125 patients in this study. Delayed bleeding occurred in 13 (10.4%) patients (95% confidence interval: 5.7-17.1%), which did not meet the pre-specified threshold of 15% (p = 0.09), and late delayed bleeding occurred in 7.2%. Bleeding rates were higher in DAPT (28.6%) than in anticoagulant users (9.3%). Blood transfusion was required in 5.6% of the patients, and thromboembolic events occurred in 0.8%. CONCLUSIONS: The prespecified efficacy threshold was not met. Delayed bleeding occurred in 10.4% of patients receiving anticoagulants or DAPT. Further controlled studies are needed to determine whether PGA shielding provides clinical benefit in this high-risk population.
引用
- Tsuji Y, Mizutani H, Hirasawa K, et al. Outcomes of polyglycolic acid sheet shielding after gastric endoscopic submucosal dissection in patients receiving anticoagulants or dual antiplatelet therapy: a prospective multicenter study. Gastrointest Endosc. 2026. PMID: 42962725. doi:10.1016/j.gie.2026.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。